|
dna metabolic process
|
GO:0006259 |
303 |
1.000
|
|
|
dna repair
|
GO:0006281 |
107 |
1.000
|
Human |
|
dna recombination
|
GO:0006310 |
92 |
1.000
|
Human |
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
1.000
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
1.000
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
1.000
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
1.000
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.999
|
Human |
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.999
|
Human |
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.999
|
|
|
recombinational repair
|
GO:0000725 |
21 |
0.999
|
Human |
|
meiosis i
|
GO:0007127 |
60 |
0.998
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.997
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.996
|
Human |
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.996
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
19 |
0.996
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
21 |
0.996
|
Human |
|
reciprocal dna recombination
|
GO:0035825 |
16 |
0.995
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.994
|
Human |
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.993
|
Human |
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.993
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.991
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.990
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.989
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.988
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.985
|
Human |
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.983
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.982
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
16 |
0.982
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.978
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.976
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.975
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.974
|
|
|
dna replication
|
GO:0006260 |
52 |
0.973
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.965
|
Human |
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.964
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
8 |
0.964
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.964
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.964
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.960
|
|
|
regionalization
|
GO:0003002 |
337 |
0.959
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.958
|
|
|
cell division
|
GO:0051301 |
120 |
0.951
|
|
|
centrosome cycle
|
GO:0007098 |
23 |
0.951
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.947
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.943
|
Human |
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.937
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.937
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.930
|
Human |
|
cell aging
|
GO:0007569 |
35 |
0.928
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.927
|
Human |
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.925
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.925
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.923
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.918
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.917
|
Human |
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.914
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.913
|
Human |
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.912
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.905
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.904
|
Human |
|
negative regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0071930 |
1 |
0.901
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.898
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.896
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.896
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.895
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.891
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.887
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
3 |
0.884
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.883
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.882
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.875
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.872
|
|
|
response to uv
|
GO:0009411 |
44 |
0.862
|
|
|
response to caffeine
|
GO:0031000 |
6 |
0.861
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.856
|
|
|
negative regulation of mammary gland epithelial cell proliferation
|
GO:0033600 |
3 |
0.848
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
8 |
0.848
|
Human |
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.840
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.837
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.825
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.823
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.821
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.816
|
|
|
female meiotic division
|
GO:0007143 |
21 |
0.814
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.814
|
Human |
|
chromatin modification
|
GO:0016568 |
187 |
0.806
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.801
|
|
|
replication fork protection
|
GO:0048478 |
1 |
0.794
|
|
|
dna catabolic process exonucleolytic
|
GO:0000738 |
3 |
0.788
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.778
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.771
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.763
|
|
|
dna catabolic process
|
GO:0006308 |
19 |
0.763
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.761
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.758
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.747
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.737
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.730
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
2 |
0.726
|
|
|
non recombinational repair
|
GO:0000726 |
10 |
0.719
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.713
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.711
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.706
|
Human |
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.703
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.695
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.694
|
Human |
|
oocyte differentiation
|
GO:0009994 |
35 |
0.689
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.683
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.665
|
|
|
regulation of dna replication
|
GO:0006275 |
17 |
0.662
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
14 |
0.658
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.655
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.651
|
|
|
regulation of cytokinesis
|
GO:0032465 |
5 |
0.651
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.648
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.645
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.641
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.634
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.633
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.618
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.618
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.603
|
|
|
mitochondrial dna repair
|
GO:0043504 |
3 |
0.582
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.566
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
20 |
0.557
|
|
|
centrosome duplication
|
GO:0051298 |
16 |
0.553
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.553
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.551
|
|
|
translesion synthesis
|
GO:0019985 |
1 |
0.549
|
|
|
mammary gland epithelial cell proliferation
|
GO:0033598 |
24 |
0.542
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
19 |
0.536
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.534
|
Human |
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.533
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.525
|
|
|
telomere capping
|
GO:0016233 |
4 |
0.524
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.523
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.521
|
|
|
mitotic spindle assembly checkpoint
|
GO:0007094 |
7 |
0.521
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.511
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.508
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.502
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.498
|
|
|
replicative senescence
|
GO:0090399 |
2 |
0.497
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.492
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.492
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.488
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.477
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.468
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.467
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.458
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.457
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
3 |
0.455
|
|
|
chromosome condensation
|
GO:0030261 |
10 |
0.454
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.446
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.444
|
|
|
metaphase anaphase transition of mitotic cell cycle
|
GO:0007091 |
9 |
0.441
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.432
|
|
|
response to gamma radiation
|
GO:0010332 |
22 |
0.431
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.431
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.428
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.426
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.413
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.412
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.412
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.409
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.400
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
10 |
0.398
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.396
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.396
|
|
|
negative regulation of dna dependent dna replication
|
GO:2000104 |
1 |
0.391
|
|
|
regulation of mitotic sister chromatid segregation
|
GO:0033047 |
12 |
0.388
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.387
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.386
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.383
|
|
|
mitotic recombination
|
GO:0006312 |
3 |
0.379
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.372
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.365
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.362
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.359
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.358
|
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.357
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.356
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.349
|
Human Rat |
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.349
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.348
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
2 |
0.345
|
|
|
attachment of spindle microtubules to kinetochore
|
GO:0008608 |
4 |
0.345
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.337
|
Human |
|
metaphase plate congression
|
GO:0051310 |
2 |
0.336
|
|
|
regulation of metaphase anaphase transition of cell cycle
|
GO:1902099 |
9 |
0.334
|
|
|
cellular response to light stimulus
|
GO:0071482 |
19 |
0.330
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.315
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.314
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.313
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.308
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.304
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.299
|
|
|
cohesin localization to chromatin
|
GO:0071921 |
1 |
0.295
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.291
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.289
|
|
|
negative regulation of cell division
|
GO:0051782 |
24 |
0.283
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.282
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.281
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.278
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.275
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.275
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
21 |
0.275
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.274
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.272
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.270
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.262
|
|
|
dna duplex unwinding
|
GO:0032508 |
7 |
0.260
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.260
|
|
|
dna geometric change
|
GO:0032392 |
7 |
0.258
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.257
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
9 |
0.257
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.256
|
|
|
regulation of cohesin localization to chromatin
|
GO:0071922 |
1 |
0.254
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.253
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.252
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.251
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.249
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.247
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.247
|
|
|
regulation of dna dependent dna replication
|
GO:0090329 |
8 |
0.241
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.240
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.239
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.238
|
|
|
regulation of mammary gland epithelial cell proliferation
|
GO:0033599 |
12 |
0.238
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.232
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.227
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.227
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.227
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.222
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.222
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.221
|
|
|
negative regulation of cell cycle arrest
|
GO:0071157 |
1 |
0.220
|
|
|
positive regulation of g2 m transition of mitotic cell cycle
|
GO:0010971 |
5 |
0.216
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.208
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.206
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.203
|
|
|
gland development
|
GO:0048732 |
330 |
0.202
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
21 |
0.201
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.200
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.200
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.195
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.192
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.192
|
|
|
gonad development
|
GO:0008406 |
141 |
0.192
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.191
|
Human |
|
t cell receptor v d j recombination
|
GO:0033153 |
5 |
0.188
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.187
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.186
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.185
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.184
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.184
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.183
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.182
|
|
|
regulation of mitotic metaphase anaphase transition
|
GO:0030071 |
8 |
0.180
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.178
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.176
|
Human |
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.176
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.175
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.174
|
|
|
histone modification
|
GO:0016570 |
159 |
0.173
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.173
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.167
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.166
|
|
|
protein localization to chromatin
|
GO:0071168 |
3 |
0.165
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.162
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.162
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.161
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.159
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.158
|
|
|
response to uv c
|
GO:0010225 |
3 |
0.157
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.155
|
|
|
negative regulation of mitotic sister chromatid segregation
|
GO:0033048 |
7 |
0.155
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.154
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.151
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.149
|
Human |
|
regulation of sister chromatid cohesion
|
GO:0007063 |
5 |
0.149
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.149
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.146
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.145
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.145
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.144
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.143
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.143
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.143
|
Human |
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.143
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.143
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.142
|
|
|
positive regulation of response to dna damage stimulus
|
GO:2001022 |
14 |
0.142
|
Human |
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.140
|
|
|
negative regulation of cellular senescence
|
GO:2000773 |
3 |
0.140
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.139
|
|
|
negative regulation of mitotic metaphase anaphase transition
|
GO:0045841 |
7 |
0.138
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.136
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.135
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.135
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator
|
GO:0042771 |
24 |
0.134
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.133
|
|
|
positive regulation of chromosome segregation
|
GO:0051984 |
4 |
0.132
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.131
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.130
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.130
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.130
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.130
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.128
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.128
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.126
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.126
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.123
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.122
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.121
|
|
|
synapsis
|
GO:0007129 |
34 |
0.119
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.119
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.117
|
|
|
spindle checkpoint
|
GO:0031577 |
12 |
0.115
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.114
|
Human |
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.112
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.111
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
18 |
0.111
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.109
|
|
|
mitotic cell cycle arrest
|
GO:0071850 |
4 |
0.109
|
|
|
b cell lineage commitment
|
GO:0002326 |
4 |
0.109
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.109
|
|
|
positive regulation of mitotic metaphase anaphase transition
|
GO:0045842 |
2 |
0.106
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.106
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.105
|
|
|
spindle organization
|
GO:0007051 |
28 |
0.103
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.101
|
|
|
regulation of attachment of spindle microtubules to kinetochore
|
GO:0051988 |
3 |
0.101
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.101
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.101
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.101
|
Human |
|
dna ligation
|
GO:0006266 |
3 |
0.100
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.098
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.098
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.097
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.097
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.095
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.094
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.094
|
|
|
regulation of sister chromatid segregation
|
GO:0033045 |
13 |
0.093
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.092
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.092
|
|
|
negative regulation of mitotic sister chromatid separation
|
GO:2000816 |
7 |
0.091
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.088
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.088
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.088
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.087
|
Human |
|
cell growth
|
GO:0016049 |
130 |
0.087
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.087
|
|
|
nucleotide excision repair
|
GO:0006289 |
13 |
0.087
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.086
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.085
|
|
|
regulation of mitotic sister chromatid separation
|
GO:0010965 |
12 |
0.085
|
|
|
somatic recombination of immunoglobulin genes involved in immune response
|
GO:0002204 |
36 |
0.083
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.083
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.083
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.081
|
|
|
negative regulation of lipid kinase activity
|
GO:0090219 |
1 |
0.081
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.080
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.079
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.079
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.079
|
|
|
negative regulation of sister chromatid segregation
|
GO:0033046 |
7 |
0.076
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.076
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.075
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.074
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.074
|
|
|
methylation
|
GO:0032259 |
134 |
0.074
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.073
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.073
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.073
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.072
|
|
|
rna localization
|
GO:0006403 |
23 |
0.071
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.071
|
|
|
negative regulation of mitosis
|
GO:0045839 |
10 |
0.070
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.070
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.070
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.070
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.070
|
Human |
|
histone threonine phosphorylation
|
GO:0035405 |
1 |
0.069
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.069
|
|
|
negative regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045736 |
9 |
0.069
|
|
|
regulation of meiosis i
|
GO:0060631 |
7 |
0.069
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.068
|
|
|
phosphatidylinositol 3 phosphate biosynthetic process
|
GO:0036092 |
6 |
0.068
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.068
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.067
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.067
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.067
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.067
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.067
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.067
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.066
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.066
|
|
|
base excision repair
|
GO:0006284 |
9 |
0.066
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.065
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.065
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.064
|
|
|
centriole assembly
|
GO:0098534 |
6 |
0.064
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.063
|
|
|
spindle assembly involved in female meiosis
|
GO:0007056 |
3 |
0.063
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.062
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.062
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.062
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.061
|
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.061
|
|
|
cerebrospinal fluid secretion
|
GO:0033326 |
4 |
0.061
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.061
|
|
|
spindle assembly
|
GO:0051225 |
13 |
0.061
|
|
|
astral microtubule organization
|
GO:0030953 |
3 |
0.060
|
|
|
mitotic spindle organization
|
GO:0007052 |
10 |
0.060
|
|
|
histone mrna metabolic process
|
GO:0008334 |
3 |
0.060
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.060
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.060
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.060
|
|
|
negative regulation of metaphase anaphase transition of cell cycle
|
GO:1902100 |
8 |
0.060
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.060
|
|
|
regulation of microtubule depolymerization
|
GO:0031114 |
13 |
0.060
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.059
|
|
|
traversing start control point of mitotic cell cycle
|
GO:0007089 |
2 |
0.058
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.058
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.058
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.058
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.057
|
|
|
dna hypermethylation
|
GO:0044026 |
3 |
0.057
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.057
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.056
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.056
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.056
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.056
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.056
|
|
|
dna replication checkpoint
|
GO:0000076 |
2 |
0.055
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.055
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.055
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.055
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.055
|
|
|
somatic diversification of t cell receptor genes
|
GO:0002568 |
5 |
0.054
|
|
|
positive regulation of histone h3 k27 methylation
|
GO:0061087 |
4 |
0.054
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.053
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.052
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.052
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.052
|
Human |
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.052
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.051
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.050
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.050
|
|
|
negative regulation of immature t cell proliferation
|
GO:0033087 |
3 |
0.050
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.050
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.049
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.049
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.049
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.048
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.048
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.048
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.047
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.047
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.047
|
|